More-2-Eat; Implementation of INPAC (m2E)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02800304 |
Recruitment Status :
Completed
First Posted : June 15, 2016
Last Update Posted : February 5, 2019
|
Sponsor:
University of Waterloo
Collaborator:
University of Western Ontario, Canada
Information provided by (Responsible Party):
Heather Keller, University of Waterloo
Tracking Information | ||||
---|---|---|---|---|
First Submitted Date | June 7, 2016 | |||
First Posted Date | June 15, 2016 | |||
Last Update Posted Date | February 5, 2019 | |||
Study Start Date | September 1, 2015 | |||
Actual Primary Completion Date | March 31, 2017 (Final data collection date for primary outcome measure) | |||
Current Primary Outcome Measures |
Implementation success of Integrated Nutrition Pathway for Acute Care (INPAC) [ Time Frame: admission ] INPAC is an evidence based pathway to improve detection, prevention and treatment of malnutrition in acute care. The primary outcome of this study is the trajectory and proportion of care activities that happen for a given population e.g. % screened, assessed with SGA, have standard care strategies provided etc.
|
|||
Original Primary Outcome Measures | Same as current | |||
Change History | ||||
Current Secondary Outcome Measures | Not Provided | |||
Original Secondary Outcome Measures | Not Provided | |||
Current Other Pre-specified Outcome Measures | Not Provided | |||
Original Other Pre-specified Outcome Measures | Not Provided | |||
Descriptive Information | ||||
Brief Title | More-2-Eat; Implementation of INPAC | |||
Official Title | Not Provided | |||
Brief Summary | M2E is a developmental evaluation of the implementation of the Integrated Nutrition Pathway for Acute Care, in five medical units in five hospitals in Canada. | |||
Detailed Description | Not Provided | |||
Study Type | Observational | |||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
|||
Target Follow-Up Duration | Not Provided | |||
Biospecimen | Not Provided | |||
Sampling Method | Non-Probability Sample | |||
Study Population | medical patients over the age of 18 years | |||
Condition | Acute Care Medical | |||
Intervention | Not Provided | |||
Study Groups/Cohorts | Not Provided | |||
Publications * |
|
|||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||
Recruitment Information | ||||
Recruitment Status | Completed | |||
Actual Enrollment |
5995 | |||
Original Estimated Enrollment |
2000 | |||
Actual Study Completion Date | March 31, 2017 | |||
Actual Primary Completion Date | March 31, 2017 (Final data collection date for primary outcome measure) | |||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
|||
Sex/Gender |
|
|||
Ages | 18 Years and older (Adult, Older Adult) | |||
Accepts Healthy Volunteers | No | |||
Contacts | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries | Canada | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number | NCT02800304 | |||
Other Study ID Numbers | 20590 | |||
Has Data Monitoring Committee | No | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement |
|
|||
Current Responsible Party | Heather Keller, University of Waterloo | |||
Original Responsible Party | Same as current | |||
Current Study Sponsor | University of Waterloo | |||
Original Study Sponsor | Same as current | |||
Collaborators | University of Western Ontario, Canada | |||
Investigators |
|
|||
PRS Account | University of Waterloo | |||
Verification Date | February 2019 |